Marcin Poręba
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- Protease and Inhibitor Mechanisms 12
- Oncology 24
- Peptidase Inhibition and Analysis 21
- Co-authors
- Marcin Drąg (53 shared papers)Guy Salvesen (26 shared papers)Paulina Kasperkiewicz (18 shared papers)Scott J. Snipas (17 shared papers)Katarzyna M. Groborz (17 shared papers)Wioletta Rut (14 shared papers)Boris Turk (10 shared papers)Christine C. Winterbourn (1 shared paper)
- Journals
- Journal of Biological Chemistry (5 papers)Chemical Science (5 papers)Biological Chemistry (4 papers)Cell Death and Differentiation (4 papers)FEBS Journal (4 papers)
- Partner nations
- PolandUnited StatesSlovenia
In The Last Decade
Marcin Poręba
68 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 111
- Cancer Research 393
- Oncology 665
- Molecular Biology 1.3k
- Immunology 302
- Organic Chemistry 364
Countries citing papers authored by Marcin Poręba
This map shows the geographic impact of Marcin Poręba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcin Poręba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcin Poręba more than expected).
Fields of papers citing papers by Marcin Poręba
This network shows the impact of papers produced by Marcin Poręba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcin Poręba. The network helps show where Marcin Poręba may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcin Poręba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 151 | |
| 2 | 2020 | 110 | |
| 3 | 2018 | 85 | |
| 4 | 2017 | 83 | |
| 5 | 2011 | 81 | |
| 6 | 2012 | 79 | |
| 7 | 2015 | 71 | |
| 8 | 2012 | 71 | |
| 9 | 2014 | 70 | |
| 10 | 2018 | 68 | |
| 11 | 2019 | 67 | |
| 12 | 2017 | 60 | |
| 13 | 2013 | 60 | |
| 14 | 2017 | 56 | |
| 15 | 2015 | 55 | |
| 16 | 2017 | 52 | |
| 17 | 2016 | 50 | |
| 18 | 2010 | 47 | |
| 19 | 2016 | 46 | |
| 20 | 2018 | 45 |
About Marcin Poręba
Marcin Poręba is a scholar working on Cancer Research, Oncology, Molecular Biology, Immunology and Microbiology, having authored 74 papers that have together received 2.2k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (21 papers), Protease and Inhibitor Mechanisms (12 papers), Cell death mechanisms and regulation (10 papers), Click Chemistry and Applications (8 papers), Biochemical and Structural Characterization (6 papers), Natural product bioactivities and synthesis (6 papers), RNA Interference and Gene Delivery (5 papers) and Chemical Synthesis and Analysis (5 papers). The work is most often cited by research in Cancer Research (393 citations), Oncology (665 citations), Molecular Biology (1.3k citations), Immunology (302 citations) and Organic Chemistry (364 citations). Marcin Poręba has collaborated with scholars based in Poland, United States and Slovenia. Frequent co-authors include Marcin Drąg, Guy Salvesen, Paulina Kasperkiewicz, Scott J. Snipas, Katarzyna M. Groborz, Wioletta Rut, Boris Turk, Christine C. Winterbourn, Heather A. Parker and Matej Vizovišek. Their work appears in journals such as Journal of Biological Chemistry, Chemical Science, Biological Chemistry, Cell Death and Differentiation and FEBS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.